| NCT05740007 | A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome | TERMINATED | PHASE2 | 2023-03-28 | 2025-02-06 | 2025-01-23 |
| NCT05362695 | A Study of Multiple-ascending Doses of IW-3300 in Healthy Subjects | COMPLETED | PHASE1 | 2022-05-17 | 2022-07-13 | 2022-06-30 |
| NCT05188261 | A Study of Single Ascending Doses of IW-3300 in Healthy Volunteers | COMPLETED | PHASE1 | 2022-01-18 | 2022-03-21 | 2022-03-09 |
| NCT03931785 | A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome | COMPLETED | PHASE2 | 2019-05-01 | 2020-03-11 | 2020-02-26 |
| NCT03856970 | Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers | COMPLETED | PHASE1 | 2019-03-11 | 2019-07-03 | 2019-06-25 |
| NCT03561883 | Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) | COMPLETED | PHASE3 | 2018-09-06 | 2020-11-06 | 2020-07-28 |
| NCT03561090 | A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) | TERMINATED | PHASE3 | 2018-06-20 | 2020-11-03 | 2020-10-07 |
| NCT03573908 | A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) | COMPLETED | PHASE3 | 2018-06-20 | 2019-04-10 | 2019-03-13 |
| NCT03226899 | A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment | TERMINATED | PHASE4 | 2017-07-19 | 2019-02-25 | 2019-02-25 |
| NCT02837783 | A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C) | TERMINATED | PHASE4 | 2016-12-21 | 2018-10-31 | 2018-10-31 |
| NCT02637557 | A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD) | COMPLETED | PHASE2 | 2016-03-01 | 2017-04-26 | 2017-04-26 |
| NCT02559206 | Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) | COMPLETED | PHASE2 | 2015-10-22 | 2016-09-30 | 2016-09-30 |
| NCT02291679 | Trial of Linaclotide in Patients With Chronic Idiopathic Constipation | COMPLETED | PHASE3 | 2014-10 | 2015-08 | 2015-08 |
| NCT02289846 | Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP) | COMPLETED | PHASE2 | 2014-10 | 2015-12 | 2015-12 |
| NCT02030925 | Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors | COMPLETED | PHASE2 | 2014-02 | 2014-12 | 2014-12 |
| NCT01712412 | Phase 2a Study of IW-9179 to Treat Functional Dyspepsia | TERMINATED | PHASE2 | 2012-10 | 2014-03 | 2014-02 |
| NCT01107236 | Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar Extraction | COMPLETED | PHASE2 | 2010-06 | 2010-08 | 2010-08 |
| NCT00938717 | Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) | COMPLETED | PHASE3 | 2009-07 | 2010-09 | 2010-09 |
| NCT00730171 | An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation | COMPLETED | PHASE3 | 2008-09 | 2012-03 | 2012-03 |
| NCT00730015 | Trial of Linaclotide in Patients With Chronic Constipation | COMPLETED | PHASE3 | 2008-08 | 2009-10 | 2009-08 |
| NCT00460811 | Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) | COMPLETED | PHASE2 | 2007-04 | 2008-04 | 2008-02 |
| NCT00402337 | Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation | COMPLETED | PHASE2 | 2006-11 | 2008-02 | 2007-12 |
| NCT00404001 | Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia | COMPLETED | PHASE2 | 2006-11 | 2007-07 | |
| NCT00306748 | Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation | COMPLETED | PHASE2 | 2006-03 | 2006-08 | |
| NCT00258193 | Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS | COMPLETED | PHASE2 | 2006-01 | 2006-09 | |